India to Kuwait: Ondansetron Export Trade Route
India has recorded 16 verified shipments of Ondansetron exported to Kuwait, representing a combined trade value of $1.8M USD. This corridor is served by 6 active Indian exporters, with an average shipment value of $113.8K USD. The leading Indian exporter is BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED , which accounts for 54% of total export value with 2 shipments worth $991.3K USD. On the buying side, ADVANCED TECHNOLOGY COMPANY K.S.C. is the largest importer in Kuwait with $659.6K USD in purchases. The top 3 suppliers — BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED , BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, ZENTA HEALTHCARE PRIVATE LIMITED — together control 98% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Kuwait Ondansetron corridor is one of India's established pharmaceutical export routes, with 16 shipments documented worth a combined $1.8M USD. The route is dominated by BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED , which alone accounts for roughly 54% of all export value, reflecting the consolidated nature of India's ondansetron manufacturing sector.
Across 6 active suppliers, the average shipment value stands at $113.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (65%) and air (15%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 26.8%, placing it at rank #6 among India's top ondansetron export destinations globally.
On the import side, key buyers of Indian ondansetron in Kuwait include ADVANCED TECHNOLOGY COMPANY K.S.C., ADVANCE TECHNOLOGY COMPANY K.S.C. , ADVANCED TECHNOLOGY COMPANY K.S.C. and 5 others. ADVANCED TECHNOLOGY COMPANY K.S.C. is the single largest importer with 2 shipments valued at $659.6K USD.
Route Characteristics
- Average transit19 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#6
- Annual growth+26.8%
- Demand growth+22.5%
- Regulatory ease65/100
Top 10 Indian Ondansetron Exporters to Kuwait
Showing top 10 of 6 Indian suppliers exporting Ondansetron to Kuwait, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED Avg $495.7K per shipment | 2 | $991.3K | 54.5% |
| 2 | BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED Avg $251.9K per shipment | 3 | $755.8K | 41.5% |
| 3 | ZENTA HEALTHCARE PRIVATE LIMITED Avg $20.9K per shipment | 2 | $41.9K | 2.3% |
| 4 | ZENTA HEALTHCARE PRIVATE LIMITED Avg $4.7K per shipment | 5 | $23.4K | 1.3% |
| 5 | MEDWISE OVERSEAS PRIVATE LIMITED Avg $2.0K per shipment | 3 | $6.1K | 0.3% |
| 6 | STALLION LABORATORIES PVT LTD Avg $2.0K per shipment | 1 | $2.0K | 0.1% |
This table shows the top 10 of 6 Indian companies exporting ondansetron to Kuwait, ranked by total trade value. The listed exporters are: BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED , BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, ZENTA HEALTHCARE PRIVATE LIMITED, ZENTA HEALTHCARE PRIVATE LIMITED , MEDWISE OVERSEAS PRIVATE LIMITED, STALLION LABORATORIES PVT LTD. BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED is the dominant supplier with 2 shipments worth $991.3K USD, giving it a 54% market share. The top 3 suppliers together account for 98% of the total trade value on this route.
Top 10 Ondansetron Importers in Kuwait
Showing top 10 of 8 known buyers in Kuwait receiving Ondansetron shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ondansetron in Kuwait include ADVANCED TECHNOLOGY COMPANY K.S.C., ADVANCE TECHNOLOGY COMPANY K.S.C. , ADVANCED TECHNOLOGY COMPANY K.S.C. , ADVANCED TECHNOLOGY CO, MEDICAL HEALTH COMPANY, among 8 total buyers. The largest importer is ADVANCED TECHNOLOGY COMPANY K.S.C., accounting for $659.6K USD across 2 shipments — representing 36% of all ondansetron imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ADVANCED TECHNOLOGY COMPANY K.S.C. | 2 | $659.6K | 36.2% |
| 2 | ADVANCE TECHNOLOGY COMPANY K.S.C. | 1 | $631.3K | 34.7% |
| 3 | ADVANCED TECHNOLOGY COMPANY K.S.C. | 1 | $360.0K | 19.8% |
| 4 | ADVANCED TECHNOLOGY CO | 1 | $96.2K | 5.3% |
| 5 | MEDICAL HEALTH COMPANY | 2 | $41.9K | 2.3% |
| 6 | MEDICAL HEALTH COMPANY | 5 | $23.4K | 1.3% |
| 7 | TO | 3 | $6.1K | 0.3% |
| 8 | TO THE ORDER OF | 1 | $2.0K | 0.1% |
Top 10 Ondansetron Formulations Imported by Kuwait
Showing top 10 of 11 product formulations shipped on the India to Kuwait Ondansetron route, ranked by trade value
Kuwait imports a wide range of ondansetron formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ONDANSETRON INJECTION BP 2MG/ML 4ML GLAS — accounts for $991.3K USD across 2 shipments. There are 11 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ONDANSETRON INJECTION BP 2MG/ML 4ML GLAS | 2 | $991.3K | 54.5% |
| 2 | ONDANSETRON INJ.BP2MG/ML 4ML GA (EMISTOP) AIN02142,AS PER INVOICE AND PACKING LIST | 2 | $659.6K | 36.2% |
| 3 | ONDANSETRON INJ.BP2MG/ML 4ML GA EMISTOP AIN02142 BATCH NO B5G0318A AS PER DOCUMENT | 1 | $96.2K | 5.3% |
| 4 | Z-ONDA SYRUP 30ML (ONDANSETRON ORAL SOLU | 3 | $23.4K | 1.3% |
| 5 | Z ONDA SYRUP 30ML ONDANSETRON ORAL SOLUTION 2MG 5ML SYRUP BATCH NO HL175MFG DT 02 2023EXP DT 01 2026 | 1 | $22.6K | 1.2% |
| 6 | Z-ONDA SYRUP 30ML(ONDANSETRON ORAL SOLUTION 2MG/5ML SYRUP) BATCH NO.IL090 MFG DT.02/2024 EXP DT.01/2027 | 1 | $19.2K | 1.1% |
| 7 | ONDICAN 4 INJECTION ONDANSETRON INJECTION I P BATCH NO 220 3000 NOS 1 30 USD MFG 11 22 EXP 10 24 | 1 | $3.9K | 0.2% |
| 8 | PHARMACEUTICALS DRUGS & MEDICINES : ONSTAL FORTE (ONDANSETRON TABLETS USP 8MG) ((AS PER INVOICE) | 1 | $2.0K | 0.1% |
| 9 | ONDET 4 (ONDANSETRON INJECTION IP)BATCHNO.OD23006LR | 1 | $1.5K | 0.1% |
| 10 | ONDIRON 8 MG,(ONDANSETRON INJECTION IP)BATCH NO:SPB230112,MFG.07-23,EXP.06-25NOS | 1 | $720 | 0.0% |
Showing top 10 of 11 Ondansetron formulations imported by Kuwait on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 65% sea for bulk, 15% air for urgent orders.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 5 shipments. Transit time averages 19 days by sea.
Market Dynamics
India's ondansetron exports to Kuwait are driven primarily by a handful of large-scale manufacturers. BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Kuwait benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED , BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, ZENTA HEALTHCARE PRIVATE LIMITED — together account for 98% of total trade value on this route. The average shipment value of $113.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as ondansetron inj.bp2mg/ml 4ml ga (emistop) ain02142,as per invoice and packing list and ondansetron inj.bp2mg/ml 4ml ga emistop ain02142 batch no b5g0318a as per document , suggesting that buyers in Kuwait tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, ADVANCED TECHNOLOGY COMPANY K.S.C. is the largest importer with 2 shipments worth $659.6K USD — representing 36% of all ondansetron imports from India on this route. A total of 8 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.8M
- Avg. Shipment
- $113.8K
- Suppliers
- 6
- Buyers
- 8
- Transit (Sea)
- ~19 days
- Annual Growth
- +26.8%
Related Analysis
Other Ondansetron Routes
Unlock the Full India to Kuwait Ondansetron Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 16 shipments on this route.
Frequently Asked Questions — India to Kuwait Ondansetron Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ondansetron to Kuwait?
The leading Indian exporters of Ondansetron to Kuwait are BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED , BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, ZENTA HEALTHCARE PRIVATE LIMITED. BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED holds the largest market share at approximately 54% of total trade value on this route.
Q What is the total value of Ondansetron exports from India to Kuwait?
India exports Ondansetron to Kuwait worth approximately $1.8M USD across 16 recorded shipments. The average value per shipment is $113.8K USD.
Q Which ports does India use to ship Ondansetron to Kuwait?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 5 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 65% of shipments going by sea and 15% by air.
Q How long does shipping take from India to Kuwait for Ondansetron?
The average transit time for Ondansetron shipments from India to Kuwait is approximately 19 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Kuwait Ondansetron trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 26.8% with demand growth tracking at 22.5%. The route is ranked #6 among India's top Ondansetron export destinations globally.
Q How many suppliers are active on the India to Kuwait Ondansetron route?
There are currently 6 active Indian suppliers exporting Ondansetron to Kuwait. The market is moderately concentrated with BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED accounting for 54% of total shipment value.
Q Who are the main importers of Ondansetron from India in Kuwait?
The leading importers of Indian Ondansetron in Kuwait include ADVANCED TECHNOLOGY COMPANY K.S.C., ADVANCE TECHNOLOGY COMPANY K.S.C. , ADVANCED TECHNOLOGY COMPANY K.S.C. , ADVANCED TECHNOLOGY CO, MEDICAL HEALTH COMPANY. ADVANCED TECHNOLOGY COMPANY K.S.C. is the largest buyer with 2 shipments worth $659.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Kuwait export trade corridor identified from Indian Customs (DGFT) records for Ondansetron.
- 2.Supplier/Buyer Matching: 6 Indian exporters and 8 importers in Kuwait matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 16 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
16 Verified Shipments
6 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists